TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study oleh Prasarn Manitpisitkul, Michael Brandt, Christopher M. Flores, Velga Kenigs, John A. Moyer, Gary Romano, Kevin Shalayda, Arthur J. Mayorga